​This event is part of BioBuzz’s Insights to Impact Series, a curated program designed exclusively for life sciences industry leaders and ecosystem builders. Our guest list is intentionally built to foster a high-quality, peer-driven experience.

​Overview

​Getting to IND is hard. Scaling to commercial is harder.

​Maryland is home to a quietly powerful concentration of pharmaceutical companies that have navigated that journey — building the quality systems, manufacturing infrastructure, and operational discipline required to bring drugs to market and keep them there.

​This event brings their leaders into the room.

​Through a series of focused fireside conversations, we'll explore the real decisions behind commercial-stage pharmaceutical operations — from quality systems and GMP execution to manufacturing partnerships and analytical science. No pitches, no panels of generalists. Just practitioners who have built and scaled at the highest level, sharing what they've learned.

​Whether you're scaling a program, building infrastructure, or trying to understand what operational excellence looks like at commercial stage — this conversation is for you.

​Join us at Supernus Pharmaceuticals in Rockville, Maryland.

​Agenda

​4:30 PM — Check-In + Networking

​5:00 PM — Welcome + Opening Remarks

​5:10 PM — Fireside Chat #1: Quality at Scale

​Building the systems, culture, and infrastructure that survive commercial growth

​5:30 PM — Fireside Chat #2: Manufacturing Discipline

​CMO/CDMO relationships, tech transfer, and the decisions that determine commercial readiness

​5:50 PM — Fireside Chat #3: The Analytical Edge

​How analytical science drives quality, compliance, and competitive advantage at scale

​6:10 PM — Networking

​Venue

​Supernus Pharmaceuticals

​Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

​Our diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. We are developing a broad range of novel product candidates for CNS disorders.

​For more information, please visit supernus.com.

​Partners

​This event is made possible by the TEDCO Equitech Growth Fund, which empowers Maryland’s innovation economy through strategic grants for infrastructure and workforce development.

​And our incredible sponsors:

• ​Agilent (agilent.com)

• ​Conner Strong & Buckelew (connerstrong.com)

• ​CRB (crbgroup.com)

• ​Fulton Bank (fultonbank.com)

• ​Heffron Company (heffroncompany.com)

• ​Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) (hjf.org)

• ​Kymanox (kymanox.com)

• ​Pharmaron (pharmaron.com)

• ​TEDCO (tedcomd.com)

• ​Workforce Genetics (workforcegenetics.com)

• ​Xcellon Biologics (xcellon.bio)

​Important Information

​We encourage you to share this with those in your network who are passionate about strengthening the BioHealth Capital Region’s biotech ecosystem and would benefit from attending.

​NOTE TO VENDORS + SERVICE PROVIDERS

​Vendor and Service Provider attendance is limited to ensure a high-quality, peer-driven industry experience. A select number of Vendor / Service Provider tickets ($75) are available using access code VENDOR.

​Vendors and Service Providers operating in the same category as any of our sponsors will require pre-authorization from the associated sponsor. BioBuzz reserves the right to restrict registration and entry as necessary. Refunds will be provided when tickets cannot be honored.